15
Sep
2009
ProCertus BioPharm, Inc.: Series A $2.1M
Posted in I - Series A, Q - 3Q09, R - MID WEST, X - Alopecia, X - Dermatology, X - Oral Mucositis, XX - WI
ProCertus BioPharm (Madison, WI) a clinical-stage developer of treatments to combat the side effects of chemotherapy and radiotherapy, e.g. alopecia, dermatitis and oral mucositis, closed a $2.1M Series A. Participants include Novartis Venture Fund and Venture Investors.
OnBioVC PARTNERS
-
Where is OnBioVC Content Consumed?
